Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational study

Abstract Background Aim of this study is to investigate a possible association of hypoglycemic episodes and arterial hypertension. We hypothesize that hospitalized insulin-treated diabetes patients with hypertensive crisis have more hypoglycemic episodes than their counterparts without hypertensive...

Full description

Bibliographic Details
Main Authors: Abimbola Abobarin-Adeagbo, Andreas Wienke, Matthias Girndt, Rainer U. Pliquett
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:https://doi.org/10.1186/s13098-020-00613-4
id doaj-5a35a4194b1a42b9afbe6ec4bbf04d0b
record_format Article
spelling doaj-5a35a4194b1a42b9afbe6ec4bbf04d0b2020-12-06T12:07:25ZengBMCDiabetology & Metabolic Syndrome1758-59962020-11-0112111110.1186/s13098-020-00613-4Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational studyAbimbola Abobarin-Adeagbo0Andreas Wienke1Matthias Girndt2Rainer U. Pliquett3Department of Internal Medicine II, Martin-Luther-Universität Halle-Wittenberg, Universitätsklinikum HalleInstitute of Medical Epidemiology, Biometry and Informatics, Martin-Luther-University Halle-WittenbergDepartment of Internal Medicine II, Martin-Luther-Universität Halle-Wittenberg, Universitätsklinikum HalleDepartment of Internal Medicine II, Martin-Luther-Universität Halle-Wittenberg, Universitätsklinikum HalleAbstract Background Aim of this study is to investigate a possible association of hypoglycemic episodes and arterial hypertension. We hypothesize that hospitalized insulin-treated diabetes patients with hypertensive crisis have more hypoglycemic episodes than their counterparts without hypertensive crisis on admission. Methods In a prospective, observational cohort study, 65 insulin-treated diabetes patients (type 1, type 2, type 3c) were included in Group 1, when a hypertensive crisis was present, as control patients in Group 2 without hypertensive crisis or hypoglycemia, in Group 3, when a symptomatic hypoglycemia was present on admission. All patients were subjected to open-label continuous glucose monitoring, 24-h blood-pressure- and Holter electrocardiogram recordings, and to laboratory tests including plasma catecholamines. Results 53 patients, thereof 19 Group-1, 19 Group-2, 15 Group-3 patients, completed this study. Group-1 patients had the highest maximum systolic blood pressure, a higher daily cumulative insulin dose at admission, a higher body-mass index, and a higher plasma norepinephrine than control patients of Group 2. Group-3 patients had more documented hypoglycemic episodes (0.8 ± 0.5 per 24 h) than Group-2 patients (0.2 ± 0.3 per 24 h), however, they were not different to the ones in Group-1 patients (0.4 ± 0.4 per 24 h). Plasma norepinephrine and mean arterial blood pressure were higher Group-1 and Group-3 patients than in control patients of Group 2. At discharge, the daily cumulative insulin dose was reduced in Group-1 (− 18.4 ± 24.9 units) and in Group-3 patients (− 18.6 ± 22.7 units), but remained unchanged in Group-2 control patients (− 2.9 ± 15.6 units). Conclusions An association between hypoglycemic events and uncontrolled hypertension was found in this study.https://doi.org/10.1186/s13098-020-00613-4Arterial hypertensionNorepinephrineHypoglycemiaDiabetes mellitus
collection DOAJ
language English
format Article
sources DOAJ
author Abimbola Abobarin-Adeagbo
Andreas Wienke
Matthias Girndt
Rainer U. Pliquett
spellingShingle Abimbola Abobarin-Adeagbo
Andreas Wienke
Matthias Girndt
Rainer U. Pliquett
Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational study
Diabetology & Metabolic Syndrome
Arterial hypertension
Norepinephrine
Hypoglycemia
Diabetes mellitus
author_facet Abimbola Abobarin-Adeagbo
Andreas Wienke
Matthias Girndt
Rainer U. Pliquett
author_sort Abimbola Abobarin-Adeagbo
title Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational study
title_short Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational study
title_full Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational study
title_fullStr Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational study
title_full_unstemmed Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational study
title_sort glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational study
publisher BMC
series Diabetology & Metabolic Syndrome
issn 1758-5996
publishDate 2020-11-01
description Abstract Background Aim of this study is to investigate a possible association of hypoglycemic episodes and arterial hypertension. We hypothesize that hospitalized insulin-treated diabetes patients with hypertensive crisis have more hypoglycemic episodes than their counterparts without hypertensive crisis on admission. Methods In a prospective, observational cohort study, 65 insulin-treated diabetes patients (type 1, type 2, type 3c) were included in Group 1, when a hypertensive crisis was present, as control patients in Group 2 without hypertensive crisis or hypoglycemia, in Group 3, when a symptomatic hypoglycemia was present on admission. All patients were subjected to open-label continuous glucose monitoring, 24-h blood-pressure- and Holter electrocardiogram recordings, and to laboratory tests including plasma catecholamines. Results 53 patients, thereof 19 Group-1, 19 Group-2, 15 Group-3 patients, completed this study. Group-1 patients had the highest maximum systolic blood pressure, a higher daily cumulative insulin dose at admission, a higher body-mass index, and a higher plasma norepinephrine than control patients of Group 2. Group-3 patients had more documented hypoglycemic episodes (0.8 ± 0.5 per 24 h) than Group-2 patients (0.2 ± 0.3 per 24 h), however, they were not different to the ones in Group-1 patients (0.4 ± 0.4 per 24 h). Plasma norepinephrine and mean arterial blood pressure were higher Group-1 and Group-3 patients than in control patients of Group 2. At discharge, the daily cumulative insulin dose was reduced in Group-1 (− 18.4 ± 24.9 units) and in Group-3 patients (− 18.6 ± 22.7 units), but remained unchanged in Group-2 control patients (− 2.9 ± 15.6 units). Conclusions An association between hypoglycemic events and uncontrolled hypertension was found in this study.
topic Arterial hypertension
Norepinephrine
Hypoglycemia
Diabetes mellitus
url https://doi.org/10.1186/s13098-020-00613-4
work_keys_str_mv AT abimbolaabobarinadeagbo glycopeniainducedsympathoadrenalactivationindiabetesmellitusanduncontrolledarterialhypertensionanobservationalstudy
AT andreaswienke glycopeniainducedsympathoadrenalactivationindiabetesmellitusanduncontrolledarterialhypertensionanobservationalstudy
AT matthiasgirndt glycopeniainducedsympathoadrenalactivationindiabetesmellitusanduncontrolledarterialhypertensionanobservationalstudy
AT rainerupliquett glycopeniainducedsympathoadrenalactivationindiabetesmellitusanduncontrolledarterialhypertensionanobservationalstudy
_version_ 1724399310954561536